Kråkstad, Norway

Judit Tjelmeland Østby

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Judit Tjelmeland Østby: Pioneering Isotope Preparation Methods

Introduction

Judit Tjelmeland Østby, an accomplished inventor based in Kråkstad, Norway, has made significant contributions to the field of pharmaceutical technology. With a total of two patents to her name, she is known for her innovative approaches to isotope preparation methods, particularly in the context of pharmaceutical applications.

Latest Patents

Judit’s latest innovations include a groundbreaking method for the generation of thorium (Th) of pharmaceutically tolerable purity. This invention not only outlines the purification process of thorium-227 but also presents a pharmaceutical composition that includes this purified isotope. Her second patent focuses on an advanced purification technique for separating thorium from radium (Ra). This involves a multi-step process utilizing strong base anion exchange resin and various mineral acids to produce a highly purified thorium solution, which is pivotal in developing treatments for neoplastic diseases.

Career Highlights

Judit Tjelmeland Østby currently works for Bayer AS, a globally recognized life sciences company. Her work there, coupled with her innovative patent filings, showcases her dedication to advancing pharmaceutical technologies. The significance of her inventions lies in their potential impact on medical treatments and patient care.

Collaborations

Throughout her career, Judit has collaborated with talented colleagues including Dimitrios Mantzilas and Jan Roger Karlson. These collaborative efforts have undoubtedly contributed to the advancement of her research and the successful development of her patented methods.

Conclusion

Judit Tjelmeland Østby stands out as a visionary in the field of isotope preparation, demonstrating how innovative ideas can transform pharmaceutical practices. With her dual patents and ongoing work at Bayer AS, she continues to pave the way for essential advancements in medical technology and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…